Advertisement
Home »

Inherent genome instability underlies trisomy 21-associated myeloid malignancies.

Jan 22, 2024

ABOUT THE EXPERTS

  • Chun-Chin Chen

    Stem Cell Transplantation Program, Stem Cell Program, Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA.

    Rebecca E Silberman

    David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.

    RA Capital, Boston, MA, USA.

    Duanduan Ma

    The Barbara K. Ostrom (1978) Bioinformatics and Computing Facility, Swanson Biotechnology Center, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.

    Jennifer A Perry

    Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA.

    Delan Khalid

    Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA.

    Yana Pikman

    Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA.

    Harvard Medical School, Boston, MA, USA.

    Angelika Amon

    David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.

    Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.

    Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.

    Michael T Hemann

    David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. hemann@mit.edu.

    Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. hemann@mit.edu.

    R Grant Rowe

    Stem Cell Transplantation Program, Stem Cell Program, Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA. grant_rowe@dfci.harvard.edu.

    Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA. grant_rowe@dfci.harvard.edu.

    Harvard Medical School, Boston, MA, USA. grant_rowe@dfci.harvard.edu.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement